Lapsi Health Unveils Keikku 2.0: World's First FDA-Cleared Digital Stethoscope with Integrated AI Scribe

The first multimodal device that merges auscultation, documentation, and AI analysis into one seamless workflow

AMSTERDAM and HOUSTON, Oct. 15, 2025 /PRNewswire/ -- Lapsi Health, a rapidly growing health tech innovator with roots in Europe and the U.S., today announced the launch of Keikku 2.0,(pronounced "KAY-koo") a breakthrough medical tool for clinicians. Keikku 2.0 is the first FDA-cleared digital stethoscope that listens, scribes, and supports diagnostics with AI in real time.

"Keikku 2.0 is the first multimodal device to combine clinical, administrative, and AI power in one tool," said Jhonatan Bringas Dimitriades, MD, CEO and co-founder of Lapsi Health. "For the first time, physicians can listen, document, and diagnose in real time with a single device. That means less time on paperwork and more focus on patients. We're proud to bring this innovation to market and give clinicians back hours each day to deliver better patient care."

Smarter Care, Less Paperwork

According to the American Medical Association, in primary care alone, physicians can spend an average of 36 minutes per patient visit on charting in electronic health record (EHR) systems, with some of it outside clinic hours.

Keikku 2.0 streamlines this process by automatically generating ready-to-use clinical notes that integrate directly into major EHR systems. Unlike other tools, Keikku 2.0 works with all major scribe technologies. The device works seamlessly with Keikku AI and leading third-party scribe platforms. This flexibility makes adoption simple for clinics and hospitals of any size. Data is always protected with advanced encryption and HIPAA-compliant security.

Real-Time AI Diagnostics

Beyond documentation, Keikku 2.0 supports clinical decision-making. Its multiple sensors and AI-powered auscultation analytics detect cardiac murmurs and lung sounds that may indicate disease, giving clinicians immediate, data-driven insights during routine exams. By turning sound into structured data, Keikku helps enable more personalized, precise care.

Keikku 2.0's high-definition ambient microphones capture clinical-grade sound even in noisy environments, ensuring diagnostic accuracy and patient privacy through built-in cybersecurity and encrypted data transmission. The small, portable device can be deployed on-the-go during hospital rounds, from exam room to exam room in the clinic.

Keikku is a wireless device enabled by Bluetooth and currently must be paired with a smartphone. Future technology is expected to enable the device to operate independently.

Designed by Physicians, Built for Everyday Use

Keikku 2.0 is a Class II medical device designed to fit naturally into real workflows. Lightweight, wireless, and portable, it can be used anywhere — during rounds, in the clinic, or while providing care in the field.

"As physicians, we designed Keikku 2.0 to fit seamlessly into clinical workflows. Every feature was built to improve efficiency and reduce stress for healthcare providers," said Diana van Stijn, MD, PhD, Chief Medical Officer and co-founder at Lapsi Health. "We set out to create a tool that feels familiar — like a smart medical assistant — to reduce burden and free clinicians to focus their energy on patient care."

What They're Saying About Keikku

"Just as Apple reimagined the phone, Keikku redefines listening to voice and the human body. It's not just a tool, it's a Medical Assistant," said Shafi Ahmed, MD, PhD, Professor and General Surgeon, London, England.

"A powerful tool to carry unlimited AI into my clinical practice, so I can use it responsibly," said Carlos Sendon, MD, Pulmonologist, Washington, DC.

"As a general practitioner, Keikku has completely transformed the way I approach workflow and auscultation in my daily practice," said Tamara Sunbul, MD, Chief Medical Information Officer, Riyadh, Saudi Arabia.

Availability

Keikku 2.0 is available now. Orders and product details are available at www.keikku.health.

About Lapsi Health
With offices in Amsterdam and Houston, Lapsi Health is a global health technology company transforming the future of frontline medicine through AI-driven devices. Founded by physicians and entrepreneurs Jhonatan Bringas Dimitriades, MD; Diana van Stijn, MD, PhD; Rodrigo Alvez, MBA; and Seamus Holohan, the company combines deep clinical expertise with cutting-edge technology to reimagine everyday medical tools such as the stethoscope. Backed by Modi Ventures, 1921 VC, and Mentors Fund, Lapsi Health is pioneering the next generation of medical devices that improve efficiency, accuracy, and the physician-patient experience. Its flagship platform, Keikku, is the first FDA-cleared digital stethoscope with integrated AI scribe and diagnostic capabilities. By turning sound into actionable clinical insights, Keikku enables healthcare professionals to work smarter, reduce documentation burden, and refocus on what matters most — time with patients.

Media Contact:
Mardi Larson Amendola for Lapsi Health 612.384.4383 | mlarson@acmarketingpr.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/lapsi-health-unveils-keikku-2-0-worlds-first-fda-cleared-digital-stethoscope-with-integrated-ai-scribe-302585083.html

SOURCE Lapsi Health